Aquestive Therapeutics Inc AQST:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:33 PM EDT
4.26quote price arrow down-0.21 (-4.70%)
Volume
368,866
52 week range
3.10 - 8.06
Loading...
  • Open4.40
  • Day High4.44
  • Day Low4.18
  • Prev Close4.47
  • 52 Week High8.06
  • 52 Week High Date12/15/20
  • 52 Week Low3.10
  • 52 Week Low Date07/30/21

Key Stats

  • Market Cap165.67M
  • Shares Out38.89M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta3.62
  • YTD % Change-19.44

KEY STATS

  • Open4.40
  • Day High4.44
  • Day Low4.18
  • Prev Close4.47
  • 52 Week High8.06
  • 52 Week High Date12/15/20
  • 52 Week Low3.10
  • 52 Week Low Date07/30/21
  • Market Cap165.67M
  • Shares Out38.89M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta3.62
  • YTD % Change-19.44

RATIOS/PROFITABILITY

  • EPS (TTM)-1.84
  • P/E (TTM)-2.31
  • Fwd P/E (NTM)-2.45
  • EBITDA (TTM)-40.968M
  • ROE (TTM)-3,347.45%
  • Revenue (TTM)41.88M
  • Gross Margin (TTM)68.98%
  • Net Margin (TTM)-152.73%
  • Debt To Equity (MRQ)-72.94%

EVENTS

  • Earnings Date11/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aquestive Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing differentiated products which leverage PharmFilm. Its late-stage product pipeline focused on the treatment of central nervous system (CNS), diseases and an earlier stage pipeline including treatment of anaphylaxis. Its commercialized licensed product is Suboxone, a sublingual film formulation of buprenorphine and naloxone, for the treatment of opioid dependence....
Santo Costa J.D.
Non-Executive Chairman
Keith Kendall
President
Daniel Barber
Chief Operating Officer
Ernest Toth CPA., J.D.
Chief Financial Officer
A. Mark Schobel
Chief Technology Officer
Address
30 Technology Dr
Warren, NJ
07059-5166
United States

Top Peers

SYMBOLLASTCHG%CHG
OPTN
OptiNose Inc
2.87-0.04-1.55%
CASI
CASI Pharmaceuticals Inc
1.09-0.02-1.80%
ADMP
Adamis Pharmaceuticals Corp
1.11-0.04-3.91%
KALA
Kala Pharmaceuticals Inc
2.01+0.11+5.53%
MDWD
Mediwound Ltd
3.72-0.29-7.23%